Feds Crack Down On Illegal Trafficking Of Oxycodone
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Feds Crack Down On Illegal Trafficking Of Oxycodone

Feds Crack Down On Illegal Trafficking Of Oxycodone

May 13, 2011
|
Share Article
|
Download Press Release
For Immediate Release
Contact: SA Crystal Harper
Phone Number: (571) 362-3433

ATLANTA, GA. - A federal grand jury in Atlanta returned indictments this week in two separate cases charging a total of 13 defendants from Georgia and Kentucky with illegally trafficking in oxycodone and other prescription drugs.  In the larger of the two cases, agents arrested a total of 6 defendants, all of whom appeared in federal court yesterday and today for arraignments.

The two cases arise out of intensified efforts to address Georgia's growing problem with the abuse of prescription drugs.  On March 2, 2011, United States Attorney Sally Quillian Yates and other leaders in federal, state, and local law enforcement, public policy, health and medicine, substance abuse treatment, and academia convened in a summit at Georgia State University to explore the scope of the prescription drug abuse problem and steps that can be taken to address the problem. 

 Since that time, the Georgia state legislature passed legislation on April 19 approving a prescription drug monitoring program, which will allow law enforcement and the medical board to more effectively identify and prevent the diversion and misuse of oxycodone and other abused prescription drugs. The bill currently is awaiting signature by the Governor to be enacted into law.

"The participants at the summit demonstrated that Georgia is experiencing an epidemic of prescription drug abuse that is devastating many of our communities," Ms. Yates said.  "The problem is one that law enforcement cannot solve alone, and instead will require a comprehensive effort from public health, medicine, and our communities.  With that said the indictments in these two cases show that this office will play an active role in arresting and punishing those who are contributing to prescription drug abuse."

1. Indictment returned charging 11 Georgia citizens with forging oxycodone prescriptions and trafficking in oxycodone tablets  -

A federal grand jury in Atlanta returned an indictment this week charging 11 Georgia citizens with conspiring to forge oxycodone prescriptions and trafficking in the illegally obtained oxycodone tablets. 7 of the defendants were arrested over the past 48 hours and have been arraigned. The charged defendants include:  KRISTEN NOELLE GODUTO, 27, of Marietta, Georgia; KORY JOSEPH GODUTO, 30, of Marietta, Georgia; PASQUALE PETER GODUTO, 60, of Marietta, Georgia; MARK JAMES O'BRIEN, 34, of Marietta, Georgia; LORI RENE ANDERSON, 32 of Acworth, Georgia; GEORGIA ANN HULSEY, 31 of Marietta, Georgia; PHILLIP DAVID HOBBS, 38 of Canton, Georgia; LEVI YOUNG STIGALL, 27 of Canton, Georgia; DAVID LEE TANNER, 32 of Acworth, Georgia; RYAN PATRICK TRENTO, 25, of Marietta, Georgia; and JUSTIN HOWARD, 28, of Braselton, Georgia.

Rodney G. Benson, Special Agent in (SAC) of the Atlanta Field Division of the DEA said, “These indictments have caused the dismantlement of an organization responsible for the distribution of oxycodone, a powerful and addictive opium derivative. This case is a perfect example of the success that can be accomplished when federal, state and local resources are combined to present a united front.”

United States Attorney Sally Quillian Yates said, "Prescription drug abuse is our nation's fastest-growing segment of illegal drug use, causing significantly more overdose deaths than cocaine, methamphetamine, and heroin combined.  Oxycodone remains one of the most widely abused prescription drugs, and it's also one of the most addictive and deadly drugs when not taken properly.  The forging of prescriptions is an especially harmful situation because it completely removes the oversight of a physician from the equation."  

 According to United States Attorney Yates, the charges and other information presented in court: KRISTEN NOELLE GODUTO allegedly led 10 co-defendants in a conspiracy to possess oxycodone with the intent to distribute. GODUTO manufactured prescriptions for oxycodone, and recruited others to pass the forged prescriptions throughout the Northern District of Georgia, from as far south as McDonough and Covington, Georgia, to as far north as Dalton and Blue Ridge, Georgia.  GODUTO allegedly paid those who passed the prescriptions in either cash or narcotics.  By passing these forged prescriptions, this criminal organization obtained, and attempted to obtain, over 10,000 thousand oxycodone tablets which they intended to distribute on the streets.

Oxycodone is the generic name of a prescription painkiller that is an ingredient in popular brand medications including Oxycontin, Percocet, and Roxycodone. 

The indictment charges the eleven defendants with one count of conspiring to possess a controlled substance, namely oxycodone, with the intent to distribute.  The charges carry a maximum sentence of 20 years in prison and a fine of up to $1,000,000.  In determining the actual sentence, the Court will consider the United States Sentencing Guidelines, which are not binding but provide appropriate sentencing ranges for most offenders.

In a related case, on May 11, 2011, an associate of the GODUTO organization, TERRY RANDY WALLACE, 23, of Newnan, Georgia, pleaded guilty to conspiring with KRISTEN NOELLE GODUTO and others to possess oxycodone with the intent to distribute it.  Specifically, WALLACE received forged prescriptions from GODUTO and presented the forged prescriptions at pharmacies to have them filled, thereby obtaining oxycodone tablets.  Once he obtained the oxycodone, WALLACE gave the drugs to GODUTO so that they could be distributed.

These cases are being prosecuted by Assistant United States Attorney Elizabeth M. Hathaway and are being investigated by Special Agents of the Drug Enforcement Administration, with assistance from the Cartersville Police Department, the Cherokee Multi-Agency Narcotics Squad, the Cobb County Sheriff's Office, the Smyrna Police Department, the Fannin County Sheriff's Office, the Rome Police Department, the Bartow County Sheriff's Office, and the Douglasville Sheriff's Office.

2. Indictment returned against Kentucky pair charging that they traveled to Georgia to purchase oxycodone for resale in Kentucky -

Rodney G. Benson, SAC of the Atlanta Field Division of the DEA said, “The sharp increase in the distribution of pain pills for non-medical reasons continues to be a major concern. As such, DEA and its local law enforcement counterparts will continue to target those who traffic these addictive pain medications. This case was a success because of the spirited level of law enforcement cooperation.”

In an unrelated case, on May 10, 2011, a federal grand jury returned an indictment against JAMES R. ANDERSON, 39, of Richmond, Kentucky; and GENIA S. ELAM, 31, of Richmond, Kentucky, on charges of trafficking oxycodone.  They were arraigned today before United States Magistrate Judge Gerrilyn G. Brill. ANDERSON was ordered to be detained pending trial, and ELAM is detained pending her bond hearing which is now scheduled for tomorrow, May 13, 2011, at 11 a.m.

According to United States Attorney Yates, the charges, and other information presented in court, ANDERSON and ELAM allegedly traveled from Kentucky to the Atlanta area in February 2011, and purchased from an undercover agent approximately 170 sham oxycodone tablets, which they planned to re-sell for profit throughout Kentucky.  ANDERSON and ELAM were indicted on one count of conspiracy to possess oxycodone with intent to distribute and one count of attempting to possess oxycodone with intent to distribute.  The charges carry a maximum sentence of 20 years in prison and a fine of up to $1,000,000.  In determining the actual sentence, the Court will consider the United States Sentencing Guidelines, which are not binding but provide appropriate sentencing ranges for most offenders.

This case is being prosecuted by Special Assistant United States Attorney Louis Crisostomo and is being investigated by Special Agents of the Drug Enforcement Administration.

Members of the public are reminded that the indictments described in this release only contain charges.  The defendants are presumed innocent of the charges and it will be the government's burden to prove the defendants’ guilt beyond a reasonable doubt at trial.

DEA Atlanta’s Field Division’s SAC Rodney G. Benson encourages parents, along with their children, to educate themselves about the dangers of legal and illegal drugs by visiting DEA’s interactive websites at www.justthinktwice.com, www.GetSmartAboutDrugs.com and www.dea.gov.

Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Robert Murphy Special Agent in Charge - Atlanta
@DEAAtlantaDiv
  • Facebook
  • X
  • Email
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster